The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 3, 2010, Pages 280-284

  Swords, Kelly ^a   Wallen, Eric M ^a   Pruthi, Raj S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Prostate biopsy; Prostate cancer; Race; Treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

AFRICAN AMERICANS; AGED; BIOPSY; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 77951599099     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.09.021     Document Type: Article

References (13)

1. American Cancer Society. Cancer Facts and Figures. http://www.cancer.org Accessed 3/21/08
2. National Cancer Institute. Surveillance Epidemiology and End Results. http://seer.cancer.gov Accessed 3/21/08
3. Gaston K.E., and Pruthi R.S. Racial differences in prostate cancer. NC Med J 67 (2006) 130-135
4. Smith D.S., Carvalhal G.F., Mager D.E., et al. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol 160 (1998) 1734
5. Kubricht W.S., Kattan M.W., Sartor O., et al. Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer. Urology 53 (1999) 553
6. Presti Jr. J.C., O'Dowd G.J., Miller M.C., et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169 (2003) 125-129
7. Guichard G., Larré S., Gallina A., et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1,000 consecutive patients. Eur Urol 52 (2007) 430-435
8. Krupski T.L., Kwan L., Afifi A.A., and Litwin M.S. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 23 (2005) 7881-7888
9. Denberg T.D., Beaty B.L., Kim F.J., et al. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103 (2005) 1819-1825
10. Hoffman R.M., Harlan L.C., Klabunde C.N., et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med 18 (2003) 845-853
11. Carver B.S., Bozeman C.B., Simoneaux W.J., et al. Race is not a predictor of prostate cancer detection on repeat prostate biopsy. J Urol 172 5 Pt 1 (2004) 1853-1855
12. Fowler Jr. J.E., Bigler S.A., Miles D., et al. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 163 (2000) 813
13. Harlan L., Brawley O., Pommerenke F., et al. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 13 (1995) 93-100